A detailed history of Imprint Wealth LLC transactions in Humacyte, Inc. stock. As of the latest transaction made, Imprint Wealth LLC holds 23,321 shares of HUMA stock, worth $122,901. This represents 0.02% of its overall portfolio holdings.

Number of Shares
23,321
Previous 39,703 41.26%
Holding current value
$122,901
Previous $116 Million 39.24%
% of portfolio
0.02%
Previous 0.09%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$2.57 - $4.84 $42,101 - $79,288
-16,382 Reduced 41.26%
23,321 $70.2 Million
Q4 2023

Jan 30, 2024

SELL
$1.99 - $3.12 $14,664 - $22,991
-7,369 Reduced 15.65%
39,703 $116 Million
Q3 2023

Nov 14, 2023

SELL
$2.75 - $4.48 $133,578 - $217,611
-48,574 Reduced 50.79%
47,072 $138 Million
Q2 2023

Aug 17, 2023

SELL
$2.86 - $4.97 $659,250 - $1.15 Million
-230,507 Reduced 70.67%
95,646 $326 Million
Q2 2023

Aug 15, 2023

BUY
$2.86 - $4.97 $197,437 - $343,098
69,034 Added 26.85%
326,153 $326 Million
Q1 2023

May 15, 2023

BUY
$2.11 - $3.25 $542,521 - $835,636
257,119 New
257,119 $938 Million

Others Institutions Holding HUMA

About Humacyte, Inc.


  • Ticker HUMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,007,000
  • Market Cap $543M
  • Description
  • Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...
More about HUMA
Track This Portfolio

Track Imprint Wealth LLC Portfolio

Follow Imprint Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Imprint Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Imprint Wealth LLC with notifications on news.